marijuana stocks news

NTRR: Decision to Allow Cannabis Cultivation and Sales on Indian Reservations Could Lead to More Explosive Growth in Multi-Billion-Dollar U.S. Cannabis Industry

TAMPA, Fla.–(BUSINESS WIRE)–

Neutra Corp. (NTRR) and other innovators working to serve the needs of the fast-growing U.S. cannabis industry received more good news last week when the Department of Justice announced that it would allow Native American tribes to cultivate and sell cannabis on their reservations—even in states where the plant remains outlawed. It’s a move many experts believe could trigger a massive new wave of growth in an industry forecast to be worth as much as $35 billion by 2020.

“There are more than 300 reservations in 30 states across the country,” said NTRR CEO Chris Brown. “If even a small percentage of these tribal nations elect to make cannabis available on their lands, access to the medicinal herb could soon be no more than a short car trip away for broad swaths of the United States.”

“More importantly, it should become more and more difficult for the federal government to justify cannabis’ status as a Schedule 1 drug if millions of Americans can purchase it safely and responsibly at a neighborhood dispensary or a nearby reservation,” he added.

Tribes will have to follow the same federal guidelines for legalizing the plant as the four states that have already elected to do so, including preventing distribution to minors and ensuring that proceeds do not go to gangs or cartels.

NTRR is preparing for the phenomenal growth predicted to come in the U.S. cannabis industry by working to deliver innovative new products to serve the rapidly expanding marketplace. Earlier this year, NTRR acquired Diamond Anvil Designs, a cutting-edge developer of smoke-free nutraceutical delivery systems that can be adapted to deliver a variety of substances, including dry herbs, oils and waxes. The lightweight, portable vapor pen represents a major breakthrough in vaporization technology thanks to customizable power levels, multi-substance vaporization capacity and best-in-class durability.

For more information on NTRR’s initiatives, please visit www.neutracorp.com.

About Neutra Corp.

Neutra Corp. is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products. By delivering a variety of new technologies designed to ensure safer, more reliable access to cannabis in approved markets, Neutra Corp. plans to compete alongside GW Pharmaceuticals (GWPRF), Growlife Inc. (PHOT) and Medbox Inc. (MDBX) and other leaders in the fast-growing, billion-dollar U.S. cannabis industry. For investing information and performance data, please visit www.neutracorp.com.

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone’s past success, either financial or strategic, is no guarantee of success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.

Contact:
Neutra Corp.
Chris Brown, 813-367-2041
President and CEO
info@neutracorp.com

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Green Thumb Industries Inc. (GTBIF) to Hold Fourth Quarter and Full Year 2022 Earnings Conference Call

Green Thumb Industries to Hold Fourth Quarter and Full Year 2022 Earnings…

AbbVie (ABBV) Announces Extension of Review for Supplemental New Drug Application of Upadacitinib

AbbVie Announces Extension of Review for Supplemental New Drug Application of Upadacitinib…

$ATTBF Agreement Terminated by Vertical Designs

Vertical Designs Terminates Abbatis Licence VANCOUVER, Dec. 30, 2014 /CNW/ – Vertical Designs…